Category Biology/Biotechnology

Synthetic Peptide can Inhibit Toxicity, Aggregation of protein in Alzheimer’s disease

a chemical structure of a peptide

Ball-and-stick model of the structure of AP407, one of the synthetic alpha sheet peptides designed by the research team to inhibit toxic oligomers of amyloid beta.Shea et al., PNAS, 2019

Researchers have developed synthetic peptides that target and inhibit the small, toxic protein aggregates that are thought to trigger Alzheimer’s disease. Neurons in the human brain make a protein called amyloid beta. Such proteins on their own, called monomers of amyloid beta, perform important tasks for neurons. But in the brains of people with Alzheimer’s disease, amyloid beta monomers have abandoned their jobs and joined together. First, they form oligomers – small clumps of up to a dozen proteins – then longer strands and finally large deposits called plaques...

Read More

Scientists advance Creation of ‘Artificial Lymph node’ to fight Cancer, other diseases

T-cells interacting with the transparent gel.
Credit: Hawley Pruitt

In a proof-of-principle study in mice, scientists at Johns Hopkins Medicine report the creation of a specialized gel that acts like a lymph node to successfully activate and multiply cancer-fighting immune system T-cells. The work puts scientists a step closer, they say, to injecting such artificial lymph nodes into people and sparking T-cells to fight disease.

In the past few years, a wave of discoveries has advanced new techniques to use T-cells – a type of white blood cell – in cancer treatment. To be successful, the cells must be primed, or taught, to spot and react to molecular flags that dot the surfaces of cancer cells...

Read More

Gene Therapy Restores Immunity in Infants with Rare Immunodeficiency disease

A baby's foot and leg

E Mamcarz et al. Lentiviral gene therapy with low dose busulfan for infants with X-SCIDThe New England Journal of Medicine, April 17, 2019; DOI: 10.1056/NEJMoa1815408 ABbaby’s foot and leg
Credit: NIAID

A small clinical trial has shown that gene therapy can safely correct the immune systems of infants newly diagnosed with a rare, life-threatening inherited disorder in which infection-fighting immune cells do not develop or function normally. Eight infants with the disorder, called X-linked severe combined immunodeficiency (X-SCID), received an experimental gene therapy co-developed by National Institutes of Health scientists. They experienced substantial improvements in immune system function and were growing normally up to two years after treatment...

Read More

Engineers tap DNA to create ‘Lifelike’ Machines

Cornell professor of biological and environmental engineering Dan Luo and research associate Shogo Hamada have created a DNA material capable of metabolism, in addition to self-assembly and organization.
Credit: John Munson/Cornell University

Tapping into the unique nature of DNA, Cornell engineers have created simple machines constructed of biomaterials with properties of living things. Using what they call DASH (DNA-based Assembly and Synthesis of Hierarchical) materials, engineers constructed a DNA material with capabilities of metabolism, in addition to self-assembly and organization – three key traits of life.

“We are introducing a brand-new, lifelike material concept powered by its very own artificial metabolism...

Read More